Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-24-250660
Filing Date
2024-11-04
Accepted
2024-11-04 16:33:55
Documents
41
Period of Report
2024-11-04

Document Format Files

Seq Description Document Type Size
1 6-K d871673d6k.htm 6-K 9966
2 EX-99.1 d871673dex991.htm EX-99.1 15139
3 EX-99.2 d871673dex992.htm EX-99.2 43423
4 GRAPHIC g871673ex99_2p10g1.jpg GRAPHIC 85603
5 GRAPHIC g871673ex99_2p11g1.jpg GRAPHIC 313390
6 GRAPHIC g871673ex99_2p12g1.jpg GRAPHIC 275849
7 GRAPHIC g871673ex99_2p13g1.jpg GRAPHIC 383410
8 GRAPHIC g871673ex99_2p14g1.jpg GRAPHIC 81914
9 GRAPHIC g871673ex99_2p15g1.jpg GRAPHIC 180467
10 GRAPHIC g871673ex99_2p16g1.jpg GRAPHIC 236473
11 GRAPHIC g871673ex99_2p17g1.jpg GRAPHIC 240383
12 GRAPHIC g871673ex99_2p18g1.jpg GRAPHIC 340727
13 GRAPHIC g871673ex99_2p19g1.jpg GRAPHIC 63049
14 GRAPHIC g871673ex99_2p1g1.jpg GRAPHIC 167761
15 GRAPHIC g871673ex99_2p20g1.jpg GRAPHIC 228018
16 GRAPHIC g871673ex99_2p21g1.jpg GRAPHIC 344071
17 GRAPHIC g871673ex99_2p22g1.jpg GRAPHIC 343839
18 GRAPHIC g871673ex99_2p23g1.jpg GRAPHIC 57799
19 GRAPHIC g871673ex99_2p24g1.jpg GRAPHIC 307788
20 GRAPHIC g871673ex99_2p25g1.jpg GRAPHIC 418626
21 GRAPHIC g871673ex99_2p26g1.jpg GRAPHIC 58551
22 GRAPHIC g871673ex99_2p27g1.jpg GRAPHIC 409935
23 GRAPHIC g871673ex99_2p28g1.jpg GRAPHIC 243741
24 GRAPHIC g871673ex99_2p29g1.jpg GRAPHIC 50331
25 GRAPHIC g871673ex99_2p2g1.jpg GRAPHIC 588219
26 GRAPHIC g871673ex99_2p30g1.jpg GRAPHIC 299268
27 GRAPHIC g871673ex99_2p31g1.jpg GRAPHIC 282383
28 GRAPHIC g871673ex99_2p32g1.jpg GRAPHIC 373938
29 GRAPHIC g871673ex99_2p33g1.jpg GRAPHIC 291977
30 GRAPHIC g871673ex99_2p34g1.jpg GRAPHIC 62752
31 GRAPHIC g871673ex99_2p35g1.jpg GRAPHIC 365689
32 GRAPHIC g871673ex99_2p36g1.jpg GRAPHIC 311317
33 GRAPHIC g871673ex99_2p37g1.jpg GRAPHIC 80431
34 GRAPHIC g871673ex99_2p3g1.jpg GRAPHIC 347193
35 GRAPHIC g871673ex99_2p4g1.jpg GRAPHIC 361158
36 GRAPHIC g871673ex99_2p5g1.jpg GRAPHIC 254569
37 GRAPHIC g871673ex99_2p6g1.jpg GRAPHIC 290371
38 GRAPHIC g871673ex99_2p7g1.jpg GRAPHIC 78760
39 GRAPHIC g871673ex99_2p8g1.jpg GRAPHIC 232362
40 GRAPHIC g871673ex99_2p9g1.jpg GRAPHIC 348030
41 GRAPHIC g871673g1104201849716.jpg GRAPHIC 2573
  Complete submission text file 0001193125-24-250660.txt   13024196
Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-29962 | Film No.: 241424118
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)